📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial. (2018)

First Author: Maher TM

Attributed to: Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2018-000325

PubMed Identifier: 30167310

Publication URI: http://europepmc.org/abstract/MED/30167310

Type: Journal Article/Review

Volume: 5

Parent Publication: BMJ open respiratory research

Issue: 1

ISSN: 2052-4439